project id: TCGA-UCEC; case submitter id: TCGA-BS-A0UV; selected normal wgs: true; source center: 23; state: released; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 55; days to birth: -20266; ethnicity: not hispanic or latino; gender: female; race: native hawaiian or other pacific islander; vital status: Alive; year of birth: 1950; age at diagnosis: 20266; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2228.0; figo stage: Stage IIIC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1902; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-BS-A0UV-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 57.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor nuclei: 90.0;